TapewireFind a company

person · Reporting owner

Wise John Drayton

Disclosed activity across 1 company

Tapewire entity
83489
SEC CIK
0001930805

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
INSMED IncINSM · Entity 3174Chief Commercial OfficerFebruary 05, 2025February 07, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

INSMED Inc

Report date February 05, 2025 · Filed February 07, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect133,015 Ending reported balance After 2025-02-07 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2025-02-05 · Grant · Acquired 15,373 · Balance 140,935

F1: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Row 2 · 2025-02-06 · Sale · Disposed 7,910 · Balance 133,025

F2: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3: This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Row 3 · 2025-02-07 · Sale · Disposed 10 · Balance 133,015

F2: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

F2: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3: This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 07, 2025 Filed Feb 7, 2025 22:11 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 10 $78.91 $789.10
Disclosure

SEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,015

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

Read SEC document
February 06, 2025 Filed Feb 7, 2025 22:11 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 7,910 $80.90 $639,919.00
Disclosure

SEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,025

F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 22:11 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 15,373 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-004460 · wk-form4_1738966262.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,935

F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.

Read SEC document
January 10, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 287 $65.40 $18,769.80
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 6

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,562

F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 31,930 $0.00 Strike: $65.72 $0.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · derivative · entry 8

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,930

Underlying: Common Stock · 31,930 shares

Expires 2035-01-08

F8 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 6,657 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 5

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,849

F5 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F6 · price: Each RSU was granted on January 8, 2025 for no consideration.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 392 $66.21 $25,954.32
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 4

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,192

F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.07 $0.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · derivative · entry 7

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2025-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 2,908 $65.87 $191,549.96
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,584

F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 10,000 $65.98 $659,800.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,492

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 10,000 $16.07 $160,700.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 6,250 $0.00 Strike: $12.58 $0.00
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · derivative · entry 4

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2024-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 6,250 $50.00 $312,500.00
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,657

F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 6,250 $12.58 $78,625.00
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:46 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,602 $48.95 $78,417.90
Disclosure

SEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,657

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 14, 2024 Filed May 15, 2024 20:39 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 5,088 $25.47 $129,591.36
Disclosure

SEC source: 0001628280-24-023613 · wk-form4_1715805527.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,259

F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 5,088 shares sold at prices ranging from $25.45 to $25.50 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 13, 2024 Filed May 15, 2024 20:39 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 71,160 $0.00 Strike: $25.83 $0.00
Disclosure

SEC source: 0001628280-24-023613 · wk-form4_1715805527.xml · derivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,160

Underlying: Common Stock · 71,160 shares

Expires 2034-05-13

F5 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.

Read SEC document
May 13, 2024 Filed May 15, 2024 20:39 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 14,518 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-023613 · wk-form4_1715805527.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,347

F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F2 · price: Each RSU was granted on May 13, 2024 for no consideration.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 21:13 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,861 $28.78 $53,559.58
Disclosure

SEC source: 0001628280-24-001166 · wk-form4_1705007582.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,829

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 1,861 shares sold at prices ranging from $28.76 to $28.82 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:33 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,167 $29.32 $34,216.44
Disclosure

SEC source: 0001628280-24-000698 · wk-form4_1704494003.xml · nonDerivative · entry 4

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,690

F6 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 22:33 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 63,560 $0.00 Strike: $29.13 $0.00
Disclosure

SEC source: 0001628280-24-000698 · wk-form4_1704494003.xml · derivative · entry 6

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,560

Underlying: Common Stock · 63,560 shares

Expires 2034-01-04

F8 · derivative.exercise_date: Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 22:33 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 12,873 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-000698 · wk-form4_1704494003.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,857

F4 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F5 · price: Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:33 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 20,071 $0.00 Strike: $19.11 $0.00
Disclosure

SEC source: 0001628280-24-000698 · wk-form4_1704494003.xml · derivative · entry 5

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,071 shares

Expires 2024-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:33 UTC INSMED Inc INSM · Entity 3174 SaleStock Option (right to buy) 20,071 $29.19 $585,872.49
Disclosure

SEC source: 0001628280-24-000698 · wk-form4_1704494003.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,984

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 20,071 shares sold at prices ranging from $28.915 to $29.39 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 22:33 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) 20,071 $19.11 $383,556.81
Disclosure

SEC source: 0001628280-24-000698 · wk-form4_1704494003.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 25, 2023 Filed May 26, 2023 20:05 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 3,366 $18.95 $63,785.70
Disclosure

SEC source: 0001628280-23-019941 · wf-form4_168513149079505.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,681

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 3,366 shares sold at prices ranging from $18.93 to $18.95 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 17, 2023 Filed May 17, 2023 20:16 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,913 $18.17 $34,759.21
Disclosure

SEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,047

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:16 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 381 $18.44 $7,025.64
Disclosure

SEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,960

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:16 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 593 $19.29 $11,438.97
Disclosure

SEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,341

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 593 shares sold at prices ranging from $19.29 to $19.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:15 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 146,220 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018183 · wf-form4_168418171156141.xml · derivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,220

Underlying: Common Stock · 146,220 shares

Expires 2033-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:15 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 31,662 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018183 · wf-form4_168418171156141.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,934

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:14 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 779 $17.96 $13,990.84
Disclosure

SEC source: 0001628280-23-000963 · wf-form4_167355804099417.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,272

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 779 shares sold at prices ranging from $17.93 to $17.98 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:30 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 34,860 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · derivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,860

Underlying: Common Stock · 34,860 shares

Expires 2033-01-05

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:30 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 7,598 Not disclosed Not disclosed
Disclosure

SEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,051

F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:30 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 1,160 $19.74 $22,898.40
Disclosure

SEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,453

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
November 22, 2022 Filed Nov 22, 2022 22:05 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 7,154 $18.84 $134,781.36
Disclosure

SEC source: 0001930805-22-000002 · wf-form4_166915469420395.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,613

F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

Read SEC document
August 10, 2022 Filed Aug 12, 2022 20:19 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 258 $27.79 $7,169.82
Disclosure

SEC source: 0001930805-22-000001 · wf-form4_166033556150179.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,767

F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 23, 2022 Filed May 25, 2022 20:15 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 164,580 $0.00 Strike: $20.01 $0.00
Disclosure

SEC source: 0001140361-22-020572 · form4.xml · derivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,580

Underlying: Common Stock · 164,580 shares

Expires 2032-05-23

F3 · derivative.exercise_date: In connection with the appointment of Mr. Wise as the Company's Chief Commercial Officer, the Company granted Mr. Wise an option to purchase a total of 164,580 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Wise's continued employment with the Company on each vesting date.

Read SEC document
May 23, 2022 Filed May 25, 2022 20:15 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 26,236 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-020572 · form4.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,137

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant, subject to Mr. Wise's continued employment with the Company on each vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 23, 2022, for no consideration.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.